Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
CDNA Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: May 04, 2026
Report Source: 2026 1st Quarter Report
CareDx Inc. Stock Analysis CDNA
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. The company is headquartered in Brisbane California, California and currently employs 761 full-time employees. The company went IPO on 2014-07-17. The firm is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. The company offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. The company also offers a diverse portfolio of digital solutions to transplant centers.
Read More CareDx Inc (CDNA) Chart
Key Statistics of CareDx Inc (CDNA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$24.70Volume
691.38KP/E Ratio (TTM)
-52 Week Range
Market Cap
1.11BAvg. Volume
842.36KDividend Yield
-Financial Metrics & Statements of CareDx Inc (CDNA)
FAQ's for CareDx Inc (CDNA)
- According to Musaffa’s Shariah screening methodology, CareDx Inc (CDNA) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CareDx Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in CareDx Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CareDx Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CareDx Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CareDx Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.